AVROBIO INC's ticker is AVRO and the CUSIP is 05455M100. A total of 94 filers reported holding AVROBIO INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10 | +66.7% | 6,388 | 0.0% | 0.00% | – |
| Q2 2023 | $6 | +200.0% | 6,388 | +219.4% | 0.00% | – |
| Q1 2023 | $2 | +100.0% | 2,000 | 0.0% | 0.00% | – |
| Q4 2022 | $1 | -99.9% | 2,000 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | -50.0% | 2,000 | 0.0% | 0.00% | – |
| Q2 2022 | $2,000 | -33.3% | 2,000 | 0.0% | 0.00% | – |
| Q1 2022 | $3,000 | -62.5% | 2,000 | 0.0% | 0.00% | – |
| Q4 2021 | $8,000 | -55.6% | 2,000 | 0.0% | 0.00% | – |
| Q2 2021 | $18,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
| Q1 2021 | $18,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
| Q4 2020 | $18,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
| Q3 2020 | $18,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
| Q2 2020 | $18,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
| Q1 2020 | $18,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
| Q4 2019 | $18,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
| Q3 2019 | $18,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
| Q2 2019 | $18,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
| Q1 2019 | $18,000 | – | 2,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 2,736,027 | $45,555,000 | 28.05% |
| Aisling Capital Management LP | 736,998 | $12,271,000 | 12.93% |
| Cormorant Asset Management, LP | 1,357,784 | $22,607,000 | 1.84% |
| New Leaf Venture Partners, L.L.C. | 215,550 | $3,589,000 | 0.98% |
| Eventide Asset Management | 928,891 | $14,901,000 | 0.66% |
| EMERALD ADVISERS, LLC | 380,636 | $6,338,000 | 0.31% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 372,865 | $6,208,000 | 0.29% |
| Blackstone Inc. | 2,962,325 | $49,323,000 | 0.28% |
| PFM Health Sciences, LP | 241,413 | $4,020,000 | 0.11% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 143,762 | $2,394,000 | 0.10% |